QUIDELORTHO CORP (QDEL) Stock News
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
QDEL Latest News, Press Relases and Analysis
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know.
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
QuidelOrtho’s (NASDAQ:QDEL) Q4: Beats On Revenue But Full-Year Sales Guidance Misses Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 4.7% year on year to $707.8 million. On the other hand, the company’s full-year revenue guidance of $2.71 billion at the midpoint came in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.63 per share was 8.5% above analysts’ consensus estimates.
QuidelOrtho’s (NASDAQ:QDEL) Q4: Beats On Revenue But Full-Year Sales Guidance Misses Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 4.7% year on year to $707.8 million. On the other hand, the company’s full-year revenue guidance of $2.71 billion at the midpoint came in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.63 per share was 8.5% above analysts’ consensus estimates.
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
QuidelOrtho Earnings: What To Look For From QDEL
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be announcing earnings results tomorrow afternoon. Here’s what to expect.
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ:...
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ:...
QuidelOrtho Reports Third Quarter 2024 Financial Results
QuidelOrtho to Participate in Three Upcoming Investor Conferences
QuidelOrtho to Report Third Quarter 2024 Financial Results
QuidelOrtho Announces New R&D Executive Leader
Five Below downgraded, DoorDash upgraded: Wall Street's top analyst calls
Five Below downgraded, DoorDash upgraded: Wall Street's top analyst calls
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit.
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit.